What are Recombinant hepatitis B vaccine drugs?

Recombinant hepatitis B vaccine drugs are pharmacologic agents that share a common mechanism (typically targeting Hepatitis B surface antigen (HBsAg)). 2 are currently marketed, with 7 more in clinical development.

What are the marketed Recombinant hepatitis B vaccine drugs?

Marketed Recombinant hepatitis B vaccine drugs include Vaccin GenHevac B Pasteur, Engerix-B Kinder.

Recombinant hepatitis B vaccine

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

2 marketed 7 in Phase 3

This page covers all Recombinant hepatitis B vaccine drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Hepatitis B surface antigen (HBsAg), Hepatitis B surface antigen (HBsAg); TLR4 (via MPL adjuvant).

Targets

Hepatitis B surface antigen (HBsAg) · Hepatitis B surface antigen (HBsAg); TLR4 (via MPL adjuvant)

Marketed (2)

Vaccin GenHevac B Pasteur · Central Hospital, Nancy, France · Immunology / Infectious Disease
GenHevac B Pasteur is a hepatitis B vaccine that stimulates the immune system to produce antibodies against hepatitis B surface antigen (HBsAg), providing protection against hepatitis B virus infection.
Engerix-B Kinder · GlaxoSmithKline · Immunology / Infectious Disease
Engerix-B Kinder is a hepatitis B vaccine that stimulates the immune system to produce antibodies against hepatitis B surface antigen, providing protection against hepatitis B infection.

Phase 3 pipeline (7)

Sci-B-Vac-Lot A · VBI Vaccines Inc. · Immunology / Infectious Disease
Sci-B-Vac is a recombinant hepatitis B vaccine designed to provide improved immunogenicity and broader protection against hepatitis B virus variants.
Fendrix vaccine · Henogen · Immunology / Infectious Disease
Fendrix is a recombinant hepatitis B vaccine that stimulates immune response against hepatitis B surface antigen using an AS04 adjuvant system to enhance immunogenicity.
Henogen HB vaccine · Henogen · Immunology / Infectious Disease
Henogen HB vaccine stimulates the immune system to produce antibodies and cellular immunity against hepatitis B virus surface antigen.
HBV-MPL vaccine · GlaxoSmithKline · Immunology / Infectious Disease
HBV-MPL vaccine stimulates immune response against hepatitis B virus by combining hepatitis B surface antigen with MPL (monophosphoryl lipid A), an adjuvant that enhances T-cell and B-cell activation.
HBVAXPRO 5µg · Sanofi Pasteur, a Sanofi Company · Immunology / Infectious Disease
HBVAXPRO is a recombinant hepatitis B surface antigen vaccine that stimulates the immune system to produce antibodies against hepatitis B virus.
HBV-MPL vaccine (208129) · GlaxoSmithKline · Immunology / Infectious Disease
HBV-MPL vaccine stimulates immune response against hepatitis B virus by combining hepatitis B surface antigen with MPL (monophosphoryl lipid A), a toll-like receptor 4 agonist adjuvant.
Engerix B® Pediatric · Sanofi Pasteur, a Sanofi Company · Immunology / Infectious Disease
Engerix B Pediatric is a hepatitis B vaccine that stimulates the immune system to produce antibodies against hepatitis B surface antigen, providing protection against hepatitis B infection.

Patent intelligence

recombinant hepatitis b vaccine patent landscape — aggregated cliff calendar, attackable patents, originator estates